← All stocks

Krystal Biotech, Inc.

KRYS Net selling
CIK 0001711279 #938 in the set updated 17 Sep 2026
Bought (120 mo)
$5.95M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$349.69M
$217.47M on a plan · $36.35M straight out of an exercise
Sold at will
$95.87M
150 of 559 sales
Net
−$343.74M
−$89.92M against sales at will

By person

10 insiders · 572 transactions
1,296×

Krish S. Krishnan holds 1,296 times base salary in stock. $1.10B of shares against $846.17K in salary for 2025.

Salary from the company's own proxy. The shares are what Krish S. Krishnan last reported holding, valued at $366.56, the price Common Stock was last bought or sold at on the open market here, on 4 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Krishnan Krish S
President and CEO
$2.05M (3)
$135.71M (226) scheduled
−$133.66M
2,993,408
10.11%
$1.10B
−16.9%
Krishnan Suma
President, R&D
$1.78M (5)
$135.36M (232) scheduled
−$133.58M
2,993,408
10.11%
$1.10B
−18.2%
JANNEY DANIEL
Director
$2.00M (1)
$44.01M (38) scheduled
−$42.01M
73,293
0.2476%
$26.87M
−24.1%
ROSSI DINO A
Director
$16.51M (11)
−$16.51M
50,000
0.1689%
$18.33M
ROMANO KATHRYN
Chief Accounting Officer
$12.67M (44) scheduled
−$12.67M
22,366
0.0756%
$8.20M
Gangolli Julian S
Director
$3.28M (3) scheduled
−$3.28M
0
0.0000%
$0.00
ORTH ANDREW C.
Chief Commercial Officer
$1.61M (3) scheduled
−$1.61M
100
0.0003%
$36.66K
0.0%
Thomas John Charles
EVP, General Counsel
$541.17K (2) scheduled
−$541.17K
0
0.0000%
$0.00
−100.0%
NORBY R DOUGLAS
Director
$93.78K (1)
+$93.78K
9,000
0.0304%
$3.30M
Riley Antony A
Chief Financial Officer
$30.10K (1)
+$30.10K
9,050
0.0306%
$3.32M
Insider
Date
Role
Action
Shares
Price
Amount
Thomas John Charles
25 Jun 2026
EVP, General Counsel
Sold after exercise
1,000
$347.27
$347.27K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise indirect
2,425
$274.90
$666.63K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise indirect
930
$269.50
$250.64K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise indirect
1,674
$268.67
$449.75K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise indirect
1,891
$267.37
$505.60K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise indirect
4,339
$266.62
$1.16M
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise indirect
1,604
$265.54
$425.92K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise indirect
900
$264.60
$238.14K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise indirect
62
$263.05
$16.31K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
373
$271.09
$101.12K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
370
$269.83
$99.84K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
3,963
$268.97
$1.07M
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
6,671
$268.04
$1.79M
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
11,673
$266.97
$3.12M
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
8,986
$266.18
$2.39M
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
3,557
$265.08
$942.88K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
1,733
$264.12
$457.73K
JANNEY DANIEL
24 Feb 2026
Director
Sold after exercise
569
$262.91
$149.59K
ROSSI DINO A
19 Feb 2026
Director
Sold after exercise
10,834
$262.10
$2.84M
ROSSI DINO A
19 Feb 2026
Director
Sold after exercise
8,116
$260.49
$2.11M
ROMANO KATHRYN
9 Feb 2026
Chief Accounting Officer
Sold after exercise
96
$277.88
$26.68K
ROMANO KATHRYN
9 Feb 2026
Chief Accounting Officer
Sold after exercise
400
$275.68
$110.27K
ROMANO KATHRYN
9 Feb 2026
Chief Accounting Officer
Sold after exercise
552
$274.64
$151.60K
ROMANO KATHRYN
9 Feb 2026
Chief Accounting Officer
Sold after exercise
928
$273.71
$254.00K
ROMANO KATHRYN
9 Feb 2026
Chief Accounting Officer
Sold after exercise
2,824
$272.51
$769.56K
ROMANO KATHRYN
9 Feb 2026
Chief Accounting Officer
Sold after exercise
5,700
$271.66
$1.55M
ROMANO KATHRYN
9 Feb 2026
Chief Accounting Officer
Sold after exercise
2,000
$270.56
$541.12K
Showing 250 of 572 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 160
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 341
Sales straight out of an exercise 68
Sales at will 150
Transactions with no price 0
Shares from compensation/vesting 1,370,174
Sales filed before the plan box existed 121
History held since 25 Sep 2017